Inhibition of glucuronidation in pancreatic cancer improves gemcitabine anticancer activity

Cancer Commun (Lond). 2022 Nov;42(11):1212-1216. doi: 10.1002/cac2.12365. Epub 2022 Sep 30.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Deoxycytidine* / therapeutic use
  • Gemcitabine
  • Humans
  • Pancreatic Neoplasms* / drug therapy

Substances

  • Deoxycytidine
  • Gemcitabine

Associated data

  • ClinicalTrials.gov/NCT01692873